M&A activity to fuel growth for India's pharma sector
Kaustubh Chaubal, a Moody's Vice President and Senior Analyst said, "The drive for overseas expansion comes amid the consolidation of the global pharmaceutical industry, as drug companies look to boost their product and pipeline diversity, scale and pricing power."
![M&A activity to fuel growth for India's pharma sector M&A activity to fuel growth for India's pharma sector](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_850x478/public/2016/12/12/10830-pharma-1-pixabay.jpg?itok=9c37TA33&c=c5af8c0f92ccc8e249257bf0f1cb18e8)
Indian pharmaceutical companies will continue to look for mergers and acquisition over the next two-year period to fuel growth, Moody's said.
Kaustubh Chaubal, a Moody's Vice President and Senior Analyst said, "The drive for overseas expansion comes amid the consolidation of the global pharmaceutical industry, as drug companies look to boost their product and pipeline diversity, scale and pricing power."
Subrata Ray, Senior Group Vice President, ICRA said, "M&As will also enhance the Indian companies' expertise in sophisticated, high entry barrier products, such as sterile injectables."
Ray added, "In fact, we expect leading Indian companies to focus increasingly on complex therapy segments such as controlled-release substances, injectables and biologics to plug technology and portfolio gaps."
Emerging markets like Russia, CIS countries, Latin America and Africa, have continued to strong growth opportunities for Indian companies, due to current low healthcare penetration levels and rapidly growing income levels.
Further, they said, the strong financial portfolios of the domestic pharma companies are well capable of large acquisitions because of their ability, for instance, to raise funds.
The report said, average reported EBITDA/interest coverage for the six Indian companies was a solid 20.5x and their average leverage measured by reported debt/EBITDA was 1.29x at 31 March 2016.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
![https://www.zeebiz.com/markets/stocks/photo-gallery-this-tata-group-stock-turned-every-rs-10000-of-investment-into-rs-11300-in-just-a-week-investors-richer-by-42722-crore-rupees-any-guesses-share-market-news-304023](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/26/307143-tradingpexels.jpg?itok=rw4R7EfH)
A Tata group stock just turned every Rs 10,000 of investment into Rs 11,300 in just a week, investors richer by Rs 42,722 crore; any guesses?
![https://www.zeebiz.com/markets/stocks/photo-gallery-large-cap-midcap-stocks-shares-to-buy-for-long-term-check-out-targets-nifty-sensex-303617](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/25/306716-stockks.jpg?itok=KJTrFUIK)
Stocks to buy for long term: Analysts suggest buying these 5 largecap, 4 midcap scrips; check out targets
![https://www.zeebiz.com/personal-finance/photo-gallery-nps-retirement-planning-budget-2024-nirmala-sitharaman-announcement-how-nps-rulebook-change-can-increase-corpus-income-and-monthly-pension-by-40-compound-return-303984](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/26/307102-indian-currency-pixabay-take.jpg?itok=kN21EW-9)
How your NPS retirement corpus and monthly pension can jump by 40% after this rule change; get details
![https://www.zeebiz.com/personal-finance/photo-gallery-senior-citizen-savings-scheme-scss-2024-interest-rate-calculator-post-office-how-to-get-inr-rs-50000-interest-retirement-planning-guaranteed-return-maturity-amount-small-savings-303930](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/26/307042-fd-interest-file.jpg?itok=45ZbBRWM)
How much investment do you need in this senior citizen scheme to get Rs 50,000 quarterly interest? Know here
12:04 PM IST